相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
Michael C. Sneller et al.
ARTHRITIS AND RHEUMATISM (2012)
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
S. De Vita et al.
ARTHRITIS AND RHEUMATISM (2012)
Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment
Hisham R. El Khayat et al.
HEPATOLOGY INTERNATIONAL (2012)
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
C. Ferri et al.
AUTOIMMUNITY REVIEWS (2011)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
Clodoveo Ferri et al.
ARTHRITIS AND RHEUMATISM (2010)
Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
Franco Dammacco et al.
BLOOD (2010)
Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia
David Saadoun et al.
BLOOD (2010)
Causes and Predictive Factors of Mortality in a Cohort of Patients with Hepatitis C Virus-related Cryoglobulinemic Vasculitis Treated with Antiviral Therapy
Dan-Avi Landau et al.
JOURNAL OF RHEUMATOLOGY (2010)
Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus
A. Della Rossa et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rituximab as a therapeutic tool in severe mixed Cryoglobulinemia
Dario Roccatello et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia
Supriya Joshi et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis - A long-term followup study
David Saadoun et al.
ARTHRITIS AND RHEUMATISM (2006)
Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients
G Basse et al.
TRANSPLANTATION (2005)
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
C Mazzaro et al.
JOURNAL OF HEPATOLOGY (2005)
Diagnosis, management, and treatment of hepatitis C
DB Strader et al.
HEPATOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis
P Cacoub et al.
ARTHRITIS AND RHEUMATISM (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Approaches to heterogeneity in meta-analysis
DB Petitti
STATISTICS IN MEDICINE (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
D Moher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
